![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Brewster A.M. Jorgensen T.J. Ruczinski I. Huang H.Y. Hoffman S. Thuita L. Newschaffer C. Lunn R.M. Bell D. Helzlsouer K.J.
Publisher: Springer Publishing Company
ISSN: 0167-6806
Source: Breast Cancer Research and Treatment, Vol.95, Iss.1, 2006-01, pp. : 73-80
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
XPD Lys751Gln increases the risk of breast cancer
Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)